Michael Schulder (@mschulder) 's Twitter Profile
Michael Schulder

@mschulder

ID: 100990395

calendar_today01-01-2010 14:51:10

119 Tweet

215 Followers

56 Following

Alpheus Medical (@alpheusmedical) 's Twitter Profile Photo

Going to #SNO2024 in Houston? Come hear our exciting Phase 1/2 #FIH results for #BrainCancerTreatment and learn about our proprietary  #sonodynamictherapy (SDT) solution for #glioblastoma treatment. #CancerResearch #BrainCancer #NeuroOncology #BrainTumor #GlioblastomaResearch

Going to #SNO2024 in Houston? Come hear our exciting Phase 1/2 #FIH results for #BrainCancerTreatment and learn about our proprietary  #sonodynamictherapy (SDT) solution for #glioblastoma treatment.

#CancerResearch #BrainCancer #NeuroOncology #BrainTumor #GlioblastomaResearch
Michael Schulder (@mschulder) 's Twitter Profile Photo

Northwell Neuroscience Brain Tumor Center. Rockin’ it at Society for Neurooncology 2024! #SNO2024 #NorthwellNeurosurgery #NorthwellHealth

Northwell Neuroscience Brain Tumor Center. Rockin’ it at Society for Neurooncology 2024! #SNO2024 #NorthwellNeurosurgery #NorthwellHealth
Vijay Agarwal (@drvijay_agarwal) 's Twitter Profile Photo

Honor to celebrate with an absolute legend at #SNO2024. Liz Pluhar from the University of Minnesota Brain Tumor Center has contributed more to understanding GBM than almost anyone I know. And has done it with such grace. #GOAT #canineglioma #BrainTumor

Honor to celebrate with an absolute legend at #SNO2024. Liz Pluhar from the <a href="/UMNews/">University of Minnesota</a> Brain Tumor Center has contributed more to understanding GBM than almost anyone I know. And has done it with such grace. #GOAT #canineglioma #BrainTumor
Michael Schulder (@mschulder) 's Twitter Profile Photo

Presenting Alpheus CV101 results at #SNO2024. This was a phase 1 trial proving safety and also showing prolonged survival in people with recurrent high grade glioma!

Presenting Alpheus CV101 results at #SNO2024. This was a phase 1 trial proving safety and also showing prolonged survival in people with recurrent high grade glioma!
Michael Schulder (@mschulder) 's Twitter Profile Photo

Coronal images showing distribution of rhenium-186 completely covering the tumor in our patient with recurrent glioblastoma, whom we are treating as part of the Plus Therapeutics ReSPECT-GBM trial:

Coronal images showing distribution of rhenium-186 completely covering the tumor  in our patient with recurrent glioblastoma, whom we are treating as part of the Plus Therapeutics ReSPECT-GBM trial:
Michael Schulder (@mschulder) 's Twitter Profile Photo

I was pleased to give an invited keynote address at the annual meeting of the Israeli Neurosurgical Society today! Topic: controversies in SRS for patients with brain metastases

I was pleased to give an invited keynote address at the annual meeting of the Israeli Neurosurgical Society today!
Topic: controversies in SRS for patients with brain metastases
CNS (@cns_update) 's Twitter Profile Photo

Please join us in congratulating the 2025-2026 Neurosurgery Publications Resident Fellow Danielle Golub, MD, MSCI and Deputy Resident Fellow Christopher Carr! We are excited to see what these two accomplish! Read more: bit.ly/4jfFVBB #residentfellows #CNSJournal

Please join us in congratulating the 2025-2026 <a href="/NeurosurgeryCNS/">Neurosurgery Publications</a> Resident Fellow <a href="/dgolubMD/">Danielle Golub, MD, MSCI</a> and Deputy Resident Fellow Christopher Carr! We are excited to see what these two accomplish! Read more: bit.ly/4jfFVBB
#residentfellows #CNSJournal